Fewer than 1 in 5 patients receive treatment to prevent life-threatening blood clots
Fewer than 1 in 5 patients received post-discharge therapy to prevent life-threatening blood clots — venous thrombosis — after hip- or knee-replacement surgery, report Rahme and colleagues in a retrospective cohort study. Venous thrombosis is one of the leading causes of death among hospital patients. However, elderly patients have a 70% lower chance of dying within 3 months if they take an anticoagulant drug to prevent blood clots. In this study of 10 000 people aged 65 and older in Quebec, there was wide variability between hospitals regarding the number of patients who received post-discharge therapy (thromboprophylaxis) to prevent blood clots and those who did not. Patients at teaching hospitals were less likely to receive treatment than those at community hospitals and those with higher incomes were more likely to receive these medications.
"Compared with patients who did not receive thromboprophylaxis after discharge, those who received thromboprophylaxis after discharge were at lower risk of short-term mortality," state the researchers. They found that only 1 in 5 patients actually received therapy to prevent blood clot formation, meaning 80% did not receive this treatment. Prescription drugs to prevent blood clots include warfarin, heparin and fondaparinux.
"Expert consensus guidelines recommend that patients receive thromboprophylaxis for at least 10 days after knee-replacement surgery and from 10 to 35 days following hip-replacement surgery," write Dr. Rahme and colleagues. "In spite of these recommendations, only 19% of patients in our study received thromboprophylaxis after discharge."
Further research is needed to understand the variability in treatment to determine whether it is attributed to differences in physician behaviour, health status between patients or differences between patients at teaching and community hospitals.
A related commentary by Fisher and Turpie caution that there are limitations to this study and that it might not have general application. They also point out the need for standard hospital policies, pre-printed medication orders and patient education to ensure consistent practices and compliance.
Source: Canadian Medical Association Journal
Related
- Clots traveling from lower veins may not be the cause of pulmonary embolism in trauma patientsMon, 19 Oct 2009, 17:43:32 EDT
- Image-guided treatment for deep venous thrombosis could improve patients' long-term outcomesMon, 21 Sep 2009, 7:01:14 EDT
- Statins may prevent blood clots in patients with cardiovascular diseaseTue, 3 Nov 2009, 14:16:31 EST
- Women may stop anticoagulants after blood clotsMon, 25 Aug 2008, 17:15:09 EDT
- Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legsMon, 15 Sep 2008, 9:22:28 EDT
Articles on the same topic
- Hip and knee replacement patients not receiving treatment to reduce blood clot riskMon, 2 Jun 2008, 17:36:20 EDT
Other sources
- Fewer than 1 in 5 patients receive treatment to prevent life-threatening blood clotsfrom PhysorgMon, 2 Jun 2008, 17:35:40 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Generating electricity from air flow
- Therapy 32 times more cost effective at increasing happiness than money
- Beyond genomics, biologists and engineers decode the next frontier
- Heart disease found in Egyptian mummies
- Therapy 32 times more cost effective at increasing happiness than money
- Treatment with folic acid, vitamin B12 associated with increased risk of cancer, death
- Full recovery now possible for an 'untreatable' mental illness
- 5 exercises can reduce neck, shoulder pain of women office workers
- Surface bacteria maintain skin's healthy balance
- New evidence that dark chocolate helps ease emotional stress
- African desert rift confirmed as new ocean in the making
- Scientists discover influenza's Achilles heel: Antioxidants
- Nanoparticles used in common household items caused genetic damage in mice
- New study links vitamin D deficiency to cardiovascular disease and death